These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28254999)

  • 1. A retrospective cohort study of the association between smoking and mortality after acute ST-segment elevation myocardial infarction.
    Steele L; Lloyd A; Fotheringham J; Sultan A; Iqbal J; Grech ED
    Postgrad Med J; 2017 Aug; 93(1102):489-493. PubMed ID: 28254999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of smoking on mortality after acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: a retrospective cohort outcome study at 3 years.
    Steele L; Palmer J; Lloyd A; Fotheringham J; Iqbal J; Grech ED
    J Thromb Thrombolysis; 2019 May; 47(4):520-526. PubMed ID: 30666553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in left ventricular systolic function in patients with ST elevation myocardial infarction: Evidence for smoker's paradox or pseudo-paradox?
    Acar B; Ozeke O; Unal S; Karakurt M; Kara M; Kirbas O; Sen F; Korkmaz A; Aras D; Aydogdu S
    Indian Heart J; 2016; 68(6):816-820. PubMed ID: 27931553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of a 'smoker's paradox' in field triaged ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention.
    Allahwala UK; Murphy JC; Nelson GI; Bhindi R
    Cardiovasc Revasc Med; 2013; 14(4):213-7. PubMed ID: 23856073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoker's Paradox in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Gupta T; Kolte D; Khera S; Harikrishnan P; Mujib M; Aronow WS; Jain D; Ahmed A; Cooper HA; Frishman WH; Bhatt DL; Fonarow GC; Panza JA
    J Am Heart Assoc; 2016 Apr; 5(4):. PubMed ID: 27107131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective cross-sectional study on the association between tobacco smoking and incidence of ST-segment elevation myocardial infarction and cardiovascular risk factors.
    Steele L; Lloyd A; Fotheringham J; Sultan A; Iqbal J; Grech ED
    Postgrad Med J; 2015 Sep; 91(1079):492-6. PubMed ID: 26265789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of smoking status on outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Rakowski T; Siudak Z; Dziewierz A; Dubiel JS; Dudek D
    J Thromb Thrombolysis; 2012 Oct; 34(3):397-403. PubMed ID: 22773074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoker pseudo-paradox in ST-segment elevation myocardial infarction patients.
    Janjani P; Salehi N; Asadmobini A; Siabani S; Nalini M
    Folia Med (Plovdiv); 2023 Apr; 65(2):243-250. PubMed ID: 37144309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non-ST-segment elevation acute coronary syndromes: an analysis from the ACUITY Trial (Acute Catheterization and Urgent Intervention Triage Strategy).
    Robertson JO; Ebrahimi R; Lansky AJ; Mehran R; Stone GW; Lincoff AM
    JACC Cardiovasc Interv; 2014 Apr; 7(4):372-9. PubMed ID: 24630881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of smoking on survival after myocardial infarction - smoker's paradox in Hungary?].
    El-Meouch NM; Ferenci T; Jánosi A
    Orv Hetil; 2018 Apr; 159(14):557-565. PubMed ID: 29611752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal trends in all-cause mortality of smokers versus non-smokers hospitalized with ST-segment elevation myocardial infarction.
    Arbel Y; Matetzky S; Gavrielov-Yusim N; Shlezinger M; Keren G; Roth A; Kopel E; Finkelstein A; Banai S; Klempfner R; Goldenberg I
    Int J Cardiol; 2014 Sep; 176(1):171-6. PubMed ID: 25065334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of smoking with myocardial injury and clinical outcome in patients undergoing mechanical reperfusion for ST-elevation myocardial infarction.
    Reinstadler SJ; Eitel C; Fuernau G; de Waha S; Desch S; Mende M; Metzler B; Schuler G; Thiele H; Eitel I
    Eur Heart J Cardiovasc Imaging; 2017 Jan; 18(1):39-45. PubMed ID: 26976354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI.
    Redfors B; Furer A; Selker HP; Thiele H; Patel MR; Chen S; Udelson JE; Ohman EM; Eitel I; Granger CB; Maehara A; Kirtane AJ; Généreux P; Jenkins PL; Ben-Yehuda O; Stone GW
    J Am Coll Cardiol; 2020 Apr; 75(15):1743-1754. PubMed ID: 32299585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The etiology of 'smoker's paradox' in acute myocardial infarction with special emphasis on the association with inflammation.
    Katayama T; Iwasaki Y; Sakoda N; Yoshioka M
    Int Heart J; 2008 Jan; 49(1):13-24. PubMed ID: 18360061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between smoking status and outcomes in myocardial infarction patients undergoing percutaneous coronary intervention.
    Sia CH; Ko J; Zheng H; Ho AF; Foo D; Foo LL; Lim PZ; Liew BW; Chai P; Yeo TC; Tan HC; Chua T; Chan MY; Tan JWC; Bulluck H; Hausenloy DJ
    Sci Rep; 2021 Mar; 11(1):6466. PubMed ID: 33742073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The enigma of the 'smoker's paradox': Results from a single-center registry of patients with STEMI undergoing primary percutaneous coronary intervention.
    Paradossi U; De Caterina AR; Trimarchi G; Pizzino F; Bastiani L; Dossi F; Raccis M; Bianchi G; Palmieri C; de Gregorio C; Andò G; Berti S
    Cardiovasc Revasc Med; 2024 Dec; 69():42-49. PubMed ID: 38862370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking paradox in coronary function and structure of acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Zhang S; Lin Z; Yu B; Liu J; Jin J; Li G; Dong H
    BMC Cardiovasc Disord; 2024 Aug; 24(1):427. PubMed ID: 39143506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and angiographic profiles and six months outcomes of smokers with acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary angioplasty.
    Gupta A; Verma SK; Sharma R; Parakh N; Ramakrishnan S; Roy A; Singh S; Sharma G; Karthikeyan G; Naik N; Yadav R; Mishra S; Seth S; Narang R; Goswami KC; Bhargava B; Bahl VK
    Indian Heart J; 2018; 70(5):680-684. PubMed ID: 30392506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Smoker's Paradox Revisited: A Patient-Level Pooled Analysis of 18 Randomized Controlled Trials.
    Yadav M; Mintz GS; Généreux P; Liu M; McAndrew T; Redfors B; Madhavan MV; Leon MB; Stone GW
    JACC Cardiovasc Interv; 2019 Oct; 12(19):1941-1950. PubMed ID: 31521646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism involved in the paradoxical effects of active smoking following primary angioplasty: a subanalysis of the protection of distal embolization in high-risk patients with acute myocardial infarction trial.
    Albertal M; Cura F; Escudero AG; Thierer J; Trivi M; Padilla LT; Belardi J;
    J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):810-2. PubMed ID: 18607246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.